| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_86f9fd708fb86712e0772b8311214e17 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-351
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D309-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-351
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D309-10 |
| filingDate |
2015-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0433f9d00caf75e90f8af560ea35f098 |
| publicationDate |
2017-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-106543124-A |
| titleOfInvention |
dapagliflozin compound |
| abstract |
The invention belongs to pharmaceutical technology field, and in particular to the Dapagliflozin compound of stable crystal form, the invention further relates to contain the preparation method of the Dapagliflozin of above-mentioned crystal formation. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108699020-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111559997-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107714667-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108699020-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021176096-A1 |
| priorityDate |
2015-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |